Early-stage detection of BC is a critical factor for effective treatment of the disease and can
increase the survival rate of BC patients. Long non-coding RNAs can act as miRNA decoys …

Breast cancer (BC) is the most common malignancy in women in western countries. A
significant part of malignant cases is caused by genetic mutation. Mutations in the gene …

In the field of transition metal chemistry, the development of transition metal‐based drugs for
the treatment of diseases such as cancer or microbial infections with minimization of adverse …

Background The P53 protein has an essential role in several cellular processes, including
DNA repair, apoptosis, and cell cycle arrest. The pathophysiology of many cancer types has …

Introduction The PI3K/AKT pathway is activated in 43-70% of breast cancer (BC)-patients
and promotes the metastatic potential of BC cells by increasing cell proliferation, invasion …

Background The role of somatic mutations in breast cancer prognosis and management
continues to be recognized. However, data on the molecular profiles of Arab women are …

Background Breast cancer (BC) is the 2 nd most prevalent malignancy worldwide and is the
most prevalent cancer among Egyptian women. The number of newly described cancer …

Background Halofuginone hydrobromide (HF) is a synthetic analogue of the naturally
occurring quinazolinone alkaloid febrifugine, which has potential therapeutic effects against …

Background The quick and accurate identification of viruses is essential for plant disease
management. Next-generation sequencing (NGS) technology may allow the discovery …

Menopausal status affects the prognoses and consequences of breast cancer. Therefore,
this retrospective study aimed to reveal the molecular variation profile differences in breast …